β4-Galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development

Glycobiology

Volumn 20, Issue 10, 2010, Pages 1311-1322

  Nishie, Toshikazu ^a   Hikimochi, Yoko ^a   Zama, Kota ^b   Fukusumi, Yoshiyasu ^a   Ito, Mitutoshi ^a   Yokoyama, Haruka ^a   Naruse, Chie ^a   Ito, Makoto ^b   Asano, Masahide ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

galactosyltransferase; glycosphingolipid; lactosylceramide; tetraploid rescue; XEN cell

Indexed keywords

BETA 4 GALACTOSYLTRANSFERASE 5; COMPLEMENTARY DNA; GALACTOSYLTRANSFERASE; LACTOSYLCERAMIDE; UNCLASSIFIED DRUG; BETA 1,4 GALACTOSYLTRANSFERASE V; BETA-1,4-GALACTOSYLTRANSFERASE V; CDW17 ANTIGEN; GANGLIOSIDE GM3; GLYCOSPHINGOLIPID; LEUKOCYTE ANTIGEN; UDPGALACTOSE GLUCOSYLCERAMIDE GALACTOSYLTRANSFERASE; UDPGALACTOSE-GLUCOSYLCERAMIDE GALACTOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOCYST; EMBRYO DEVELOPMENT; EMBRYO MEMBRANE; ENZYME ACTIVITY; FEMALE; GENOTYPE; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TETRAPLOIDY; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENDODERM; GENETICS; GIANT CELL; HEMATOMA; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; LENTIVIRINAE; LETHAL GENE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TROPHOBLAST;

RATTUS;

ANIMALS; ANTIGENS, CD; BLASTOCYST; CELLS, CULTURED; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; ENDODERM; EXTRAEMBRYONIC MEMBRANES; FEMALE; G(M3) GANGLIOSIDE; GALACTOSYLTRANSFERASES; GENES, LETHAL; GIANT CELLS; GLYCOSPHINGOLIPIDS; HEMATOMA; HUMANS; IN SITU HYBRIDIZATION; LACTOSYLCERAMIDES; LENTIVIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; MICE, TRANSGENIC; TETRAPLOIDY; TROPHOBLASTS;

EID: 77956520108     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq098     Document Type: Article

References (52)

1. Aoki D, Appert HE, Johnson D, Wong SS, Fukuda MN. 1990. Analysis of the substrate binding sites of human galactosyltransferase by protein engineering. EMBO J. 9:3171-3178.
2. Asano M, Furukawa K, Kido M, Matsumoto S, Umesaki Y, Kochibe N, Iwakura Y. 1997. Growth retardation and early death of beta-1, 4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J. 16:1850-1857.
3. Asano M, Nakae S, Kotani N, Shirafuji N, Nambu A, Hashimoto N, Kawashima H, Hirose M,MiyasakaM, Takasaki S. 2003. Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1, 4-galactosyltransferase-I- deficient mice. Blood. 102:1678-1685.
4. Conlon RA, Herrmann BG. 1993. Detection of messenger RNA by in situ hybridization to postimplantation embryo whole mounts. Meth Enzymol. 225:373-383.
5. Downs KM, Davies T. 1993. Staging of gastrulating mouse embryos by morphological landmarks in the dissecting microscope. Development. 118: 1255-1266.
6. Fukusumi Y, Naruse C, Asano M. 2008. Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo. Dev Dyn. 237:618-629.
7. Furukawa K, Tokuda N, Okuda T, Tajima O. 2004. Glycosphingolipids in engineered mice: insights into function. Semin Cell Dev Biol. 15:389-396.
8. Guo S, Sato T, Shirane K, Furukawa K. 2001. Galactosylation of N-linked oli-gosaccharides by human beta-1, 4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology. 11:813-820.
9. Hashimoto D, Nagata T, Uchijima M, Seto S, Suda T, Chida K, Miyoshi H, Nakamura H, Koide Y. 2008. Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung. Vaccine. 26:5095-5100.
10. Hayashi Y, Horibata Y, Sakaguchi K, Okino N, Ito M. 2005. A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates. Anal Biochem. 345:181-186.
11. Hennet T. 2002. The galactosyltransferase family. Cell Mol Life Sci. 59: 1081-1095.
12. Ichikawa S, Sakiyama H, Suzuki G, Hidari KI, Hirabayashi Y. 1996. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc Natl Acad Sci USA. 93:4638-4643.
13. Inoue M, Fujii Y, Furukawa K, Okada M, Okumura K, Hayakawa T, Sugiura Y. 2002. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem. 277:29881-29888.
14. Ito H, Kameyama A, Sato T, Sukegawa M, Ishida HK, Narimatsu H. 2007. Strategy for the fine characterization of glycosyltransferase specificity using isotopomer assembly. Nat Methods. 4:577-582.
15. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3816-3821.
16. Kemler R, Brulet P, Schnebelen MT, Gaillard J, Jacob F. 1981. Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J Embryol Exp Morphol. 64:45-60.
17. Kolmakova A, Chatterjee S. 2005. Platelet derived growth factor recruits lactosylceramide to induce cell proliferation in UDP Gal:GlcCer: beta1- 4Galactosyltransferase (GalT-V) mutant Chinese hamster ovary cells. Glycoconj J. 22:401-407.
18. Kuhn R, Rajewsky K, Muller W. 1991. Generation and analysis of interleukin-4 deficient mice. Science. 254:707-710.
19. Kumagai T, Tanaka M, Yokoyama M, Sato T, Shinkai T, Furukawa K. 2009. Early lethality of beta-1, 4-galactosyltransferase V-mutant mice by growth retardation. Biochem Biophys Res Commun. 379:456-459.
20. Kunath T, Arnaud D, Uy GD, Okamoto I, Chureau C, Yamanaka Y, Heard E, Gardner RL, Avner P, Rossant J. 2005. Imprinted X-inactivation in extraembryonic endoderm cell lines from mouse blastocysts. Development. 132:1649-1661.
21. Lee J, Sundaram S, Shaper NL, Raju TS, Stanley P. 2001. Chinese hamster ovary (CHO) cells may express six beta 4-galactosyltransferases (beta 4GalTs). Consequences of the loss of functional beta 4GalT-1, beta 4GalT-6, or both in CHO glycosylation mutants. J Biol Chem. 276: 13924-13934.
22. Lo NW, Shaper JH, Pevsner J, Shaper NL. 1998. The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiol-ogy. 8:517-526.
23. Lu Q, Hasty P, Shur BD. 1997. Targeted mutation in beta1, 4-galactosyltrans-ferase leads to pituitary insufficiency and neonatal lethality. Dev Biol. 181:257-267.
24. Lu Q, Shur BD. 1997. Sperm from beta 1,4-galactosyltransferase-null mice are refractory to ZP3-induced acrosome reactions and penetrate the zona pellu-cida poorly. Development. 124:4121-4131.
25. Machingo QJ, Fritz A, Shur BD. 2006. A beta1, 4-galactosyltransferase is required for Bmp2-dependent patterning of the dorsoventral axis during zebrafish embryogenesis. Development. 133:2233-2241.
26. Matsuo I, Kuratani S, Kimura C, Takeda N, Aizawa S. 1995. Mouse Otx2 functions in the formation and patterning of rostral head. Genes Dev. 9:2646-2658.
27. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. 1998. Development of a self-inactivating lentivirus vector. J Virol. 72:8150-8157.
28. Mori R, Kondo T, Nishie T, Ohshima T, Asano M. 2004. Impairment of skin wound healing in beta-1, 4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. Am J Pathol. 164:1303-1314.
29. Nagy A, Gertsenstein M, Vintersten K, Behringer R. 2003. Production of chimeras. Manipulating the mouse embryo. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p. 453-506.
30. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA. 90:8424-8428.
31. Nakamura N, Yamakawa N, Sato T, Tojo H, Tachi C, Furukawa K. 2001. Differential gene expression of beta-1, 4-galactosyltransferases I, II and V during mouse brain development. JNeurochem. 76:29-38.
32. Nakano M, Odaka K, Ishimura M, Kondo S, Tachikawa N, Chiba J, Kanegae Y, Saito I. 2001. Efficient gene activation in cultured mammalian cells mediated by FLP recombinase-expressing recombinant adenovirus. Nucleic Acids Res. 29:E40.
33. Nishie T, Miyaishi O, Azuma H, Kameyama A, Naruse C, Hashimoto N, Yokoyama H, Narimatsu H, Wada T, Asano M. 2007. Development of immunoglobulin A nephropathy-like disease in beta-1, 4-galactosyltransferase-I-deficient mice. Am J Pathol. 170:447-456.
34. Nomura T, Takizawa M, Aoki J, et al. 1998. Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1, 4-galactosyltransferase from rat brain. J Biol Chem. 273:13570-13577.
35. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 1997. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:313-319.
36. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. 1996. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA. 93:13090-13095.
37. Rajesh M, Kolmakova A, Chatterjee S. 2005. Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endo-thelial cells. Circ Res. 97:796-804.
38. Regina Todeschini A, Hakomori SI. 2008. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 1780:421-433.
39. Sasaki H, Hogan BL. 1993. Differential expression of multiple fork head related genes during gastrulation and axial pattern formation in the mouse embryo. Development. 118:47-59.
40. Sato T, Furukawa K, Bakker H, Van Den Eijnden DH, Van DieI. 1998. Molecular cloning of a human cDNA encoding beta-1, 4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc beta-1, 4-galactosyltransferase. Proc Natl Acad Sci USA. 95:472-477.
41. SekoA, DohmaeN,Takio K, Yamashita K.2003. Beta 1, 4-galactosyltransferase (beta 4GalT)-IV is specific for GlcNAc 6-O-sulfate. Beta 4GalT-IV acts on keratan sulfate-related glycans and a precursor glycan of 6-sulfosialyl-Lewis X. J Biol Chem. 278:9150-9158.
42. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693-702.
43. Tagawa H, Kizuka Y, Ikeda T, Itoh S, Kawasaki N, Kurihara H, Onozato ML, Tojo A, Sakai T, Kawasaki T, et al. 2005. A non-sulfated form of the HNK-1 carbohydrate is expressed in mouse kidney. J Biol Chem. 280:23876-23883.
44. Van Die I, Van Tetering A, Schiphorst WE, Sato T, Furukawa K, Van Den Eijnden DH. 1999. The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation. FEBS Lett. 450:52-56.
45. Wiegandt H. (ed) 1985. Glycolipids. Amsterdam: Elsevier. p. 199-260.
46. Wilkinson DG, Bhatt S, Herrmann BG. 1990. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature. 343:657-659.
47. Yagi T, Nada S, Watanabe N, Tamemoto H, Kohmura N, Ikawa Y, Aizawa S. 1993. A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal Biochem. 214:77-86.
48. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, Sandhoff K, Proia RL. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA. 96:9142-9147.
49. Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL. 2005. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci USA. 102:2725-2730.
50. Yoshihara T, Sugihara K, Kizuka Y, Oka S, Asano M. 2009. Learning/memory impairment and reduced expression of the HNK-1 carbohydrate in beta4-galactosyltransferase-II-deficient mice. J Biol Chem. 284:12550-12561.
51. Yowler BC, Schengrund CL. 2004. Glycosphingolipids-sweets for botulinum neurotoxin. Glycoconj J. 21:287-293.
52. Zama K, Hayashi Y, Ito S, Hirabayashi Y, Inoue T, Ohno K, Okino N, Ito M. 2009. Simultaneous quantification of glucosylceramide and galactosylcera-mide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase. Glycobiology. 19:767-775.